The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection

Current Opinion in Cardiology

Volumn 12, Issue 2, 1997, Pages 146-152

  Winters, Gayle L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GRAFT INFECTION; GRAFT REJECTION; HEART FAILURE; HEART GRAFT; HEART LUNG TRANSPLANTATION; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; LYMPHOCYTIC INFILTRATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL;

EID: 0031004982     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199703000-00009     Document Type: Article

References (59)

1. Caves BC, Billingham ME, Stinson EB, Shumway NE: Serial transvenous biopsy of the transplanted human heart: improved management of acute rejection episodes. Lancet 1974, i:821-826.
2. Billingham ME: Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1982, 1:25-30.
3. McAllister HA, Schnee MJ, Radovancevic B, Frazier OH: A system for grading cardiac allograft rejection. Tex Heart Inst J 1986, 13:1-3.
4. Kemnitz J, Cohnert T, Schafers HJ, Helmke M, Wahlers T, Herrmann G, Schmidt RM, Haverich A: A classification of cardiac allograft rejection: a modification of the classification by Billingham. Am J Surg Pathol 1987, 11:503-515.
5. Schoen FJ: Myocardial, pericardial, and endocardial heart disease. In Interventional and Surgical Cardiovascular Pathology. Edited by Schoen FJ. Philadelphia: WB Saunders; 1989:173-216.
6. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA, Jones KW, O'Connell JB: Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989, 8:430-443.
7. Winters GL: The pathology of heart allograft rejection. Arch Pathol Lab Med 1991, 115:266-272.
8. O'Connell JB, Renlund DG: Variations in the diagnosis, treatment, and prevention of cardiac allograft rejection: the need for standardization? J Heart Transplant 1990, 9:269-271.
9. Billingham ME: Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. J Heart Transplant 1990, 9:272-276.
10. Billingham ME, Cary NRB, Hammond EH, Kemnitz J, Marboe C, McAllister HA, Snover DC, Winters GL, Zerbe A: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990, 9:587-593.
11. Gallo P, Grillo LR, di Gioia C, Coppola L, Francalanci P, d'Amati G: Working formulation nomenclature of heart transplant pathology: a retrospective evaluation of 1037 endomyocardial biopsies. Cardiovasc Pathol 1992, 1:87-92.
12. Nielsen H, Sorensen FB, Nielsen B, Bagger JP, Thayssen P, Baandrup U: Reproducibility of the acute rejection diagnosis in human cardiac allografts: the Stanford classification and the international grading system. J Heart Lung Transplant 1993, 12:239-243.
13. Winters GL: The International Society for Heart and Lung Transplantation working formulation for heart transplant rejection: is it making the grade? Cardiovasc Pathol 1992, 1:93-95.
14. Winters GL, McManus BM, for the Rapamycin Cardiac Rejection Treatment Trial Pathologists: Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. J Heart Lung Transplant 1996, 15:728-735. The first study to assess uniformity among pathologists from many different transplantation centers in endomyocardial biopsy interpretation using the ISHLT grading system.
15. Myles JL, Ratliff NB, McMahon JT, Golding LR, Hobbs RE, Rincon G, Sterba RW, Steward R: Reversibility of myocyte injury in moderate and severe acute rejection in cyclosporin-treated cardiac transplant patients. Arch Pathol Lab Med 1987, 111:947-952.
16. Wagoner LE, Zhao L, Bishop DK, Chan S, Xu S, Barry WH: Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts. Circulation 1996, 93:111-119.
17. Laguens RP, Cabeza Meckert PM, San Martino J, Perrone S, Favaloro R: Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J Heart Lung Transplant 1996, 15:911-918. Demonstrates apoptosis of myocardial cells during cardiac allograft rejection and correlates apoptosis with rejection grade.
18. Szabolcs M, Michler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RP, Minanov OP, Cannon PJ: Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 1996, 94:1665-1673. Demonstrates apoptosis of myocardial cells during cardiac allograft rejection and the parallel expression of inducible nitric oxide synthase.
19. Tazelaar HD, Edwards WD: Pathology of cardiac transplantation: recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayo Clin Proc 1992, 67:685-696.
20. Billingham ME: Pathology of human cardiac transplantation. In Cardiovascular Pathology: Clinicopathologic Correlations and Pathogenetic Mechanisms. Edited by Schoen FJ, Gimbrone MA. Baltimore: Williams & Wilkins: 1995:108-128.
21. Billingham ME: Cardiac transplantation. In Contemporary Issues in Cardiovascular Pathology. Edited by Waller BF. Philadelphia: FA Davis; 1988:185-199.
22. Billingham ME: The postsurgical heart: the pathology of cardiac transplantation. Am J Cardiovasc Pathol 1988, 1:319-334.
23. Hunt SA, Tazelaar HD: Use of endomyocardial biopsy in cardiac transplantation. In Cardiac Biopsy. Edited by Fowles RE. Mount Kisco, NY: Futura Publishing; 1992:155-163.
24. Kotte-Marchant K, Ratliff NB: Endomyocardial lymphocytic infiltrates in cardiac transplant recipients. Arch Pathol Lab Med 1989, 113:690-698.
25. Radio SJ, McManus BM, Winters GL, Kendall TJ, Wilson JE, Costanzo-Nordin MR, Ye Y: Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection. Mod Pathol 1991, 4:654-660.
26. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G: Cyclosporin-induced endothelial cell injury. Lab Invest 1986, 55:455-462.
27. Forbes RDC, Rowan RA, Billingham ME: Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. Hum Pathol 1990, 21:850-855.
28. Suit PF, Kottke-Marchant K, Ratliff NB, Pippenger CE, Easely K: Comparison of whole-blood cyclosporine levels and the frequency of endomyocardial lymphocytic infiltrates (the Quilty lesion) in cardiac transplantation. Transplantation 1989, 48:618-621.
29. Freimark D, Czer LS, Aleksic I, Ruan X-M, Admon D, Blanche C, Trento A, Fishbein MC: Pathogenesis of Quilty lesion in cardiac allografts: relationship to reduced endocardial cyclosporine A. J Heart Lung Transplant 1995, 14:1197-1203.
30. Fishbein MC, Bell G, Lones MA, Czer LSC, Miller JM, Harasty D, Trento A: Grade 2 cellular heart rejection: does it exist? J Heart Lung Transplant 1994, 13:1051-1057.
31. Kemnitz J: Grade 2 cellular heart rejection: does it exist? Yes! [letter]. J Heart Lung Transplant 1995, 14:800-801.
32. Pardo-Mindan FJ, Lozano MD: "Quilty effect" in heart transplantation: is it related to acute rejection? J Heart Lung Transplant 1991, 10:937-941.
33. Costanzo-Nordin MR, Winters GL, Fisher SG, O'Sullivan J, Heroux AL, Kao W, Mullen GM, Johnson MR: Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens. J Heart Lung Transplant 1993, 12:741-747.
34. Fyfe B, Loh E, Winters GL, Couper GS, Kartashov AI, Schoen FJ: Heart transplantation-associated perioperative ischemic myocardial injury: morphological features and clinical significance. Circulation 1996, 93:1133-1140. This detailed description of histologic characteristics of early ischemic injury and its healing present on early posttransplantation biopsies also addresses the frequency and clinical significance of early ischemic injury. Recognition of these lesions and differentiation from rejection could decrease unnecessary immunosuppression and its complications.
35. Day JD, Rayburn BK, Gaudin PB, Baldwin WM, Lowenstein CJ, Kasper EK, Baughman KL, Baumgartner WA, Hutchins GM, Hruban RH: Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995, 14:5142-3149. Review article addressing the theory that ischemic injury to the cardiac allograft sustained during the perioperative period contributes significantly to the development of allograft vasculopathy.
36. Winters GL, Davis SF, Anderson TJ, Ganz P, Schoen FJ: Is perioperative ischemic injury a factor in early graft arteriosclerosis: evidence from endomyocardial biopsy-intravascular ultrasound correlation [abstract]. J Heart Lung Transplant 1996, 15:S43.
37. Edwalds GM, Said JW, Block MI, Herscher LL, Siegel PJ, Fishbein MC: Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability. Hum Pathol 1984, 15:753-756.
38. Pirolo JS, Hutchins GM, Moore GW: Myocyte vacuolization in infarct border zones is reversible. Am J Pathol 1985, 121:444-450.
39. Clausell N, Butany J, Gladstone P, Lonn E, Liu P, Cardella C, Feindel C, Daly PA: Myocardial vacuolization, a marker of ischemic injury, in surveillance cardiac biopsies posttransplant: correlations with morphologic vascular disease and endothelial dysfunction. Cardiovasc Pathol 1996, 5:29-37.
40. Neish AS, Loh E, Schoen FJ: Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis. J Am Coll Cardiol 1992, 19:586-592.
41. Winters GL, Schoen FJ: Predictive value of myocardial pathology in endomyocardial biopsies from heart transplant recipients with graft arteriosclerosis [abstract]. J Heart Lung Transplant 1995, 14:S87.
42. Linder J: Infection as a complication of heart transplantation. J Heart Transplant 1988, 7:390-394.
43. Dressier FA, Javier JJ, Salinas-Madrigal L, Milligan TW, McBride LR, Labovitz AJ, Miller LW: Myocardial toxoplasmosis complicating cardiac transplant. Cardiovasc Pathol 1996, 5:101-104.
44. Lozano MD, Pardo-Mindan J: Value of the endomyocardial biopsy in the diagnosis of toxoplasmosis after heart transplantation [letter]. Cardiovasc Pathol 1996, 5:55-56.
45. Winters GL, Loh E, Schoen FJ: Natural history of focal moderate cardiac allograft rejection: is treatment warranted? Circulation 1995, 91:1975-1980.
46. Milano A, Caforio ALP, Livi U, Bauce B, Angelini A, Casarotto D, Thiene G: Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft. J Heart Lung Transplant 1996, 15:456-460.
47. Brunner-La Rocca HP, Sutsch G, Schneider J, Follath F, Kiowski W: Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation 1996, 94:1334-1338. Multivariate analysis of over 300 biopsies showed that the strongest predictor of grade 3A or greater rejection was grade 2 rejection on the previous biopsy. A strong inverse correlation between graft rejection and time interval after transplantation was demonstrated.
48. Hausen B, Ronde R, Demertzis S, Albes JM, Wahlers T, Schafers HJ: Strategies for routine biopsies in heart transplantation based on 8-year results with more than 13,000 biopsies. Eur J Cardiothorac Surg 1995, 9:592-598.
49. White JA, Guiraudon C, Pflugfelder PW, Kostuk WJ: Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant 1995, 14:1052-1056. A study of over 1000 endomyocardial biopsies performed 1 to 12 years after transplantation found that, because rejection is rare beyond 1 year after transplantation, routine surveillance biopsies performed beyond 1 year do not significantly impact patient management.
50. Sethi GK, Kosaraju S, Arabia FA, Roasdo LJ, McCarthy MS, Copeland JG: Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients? J Heart Lung Transplant 1995, 14:1047-1051. A retrospective study comparing patients who had surveillance biopsies performed beyond 6 months after transplantation with those who did not. Because no difference was found in actuarial survival rate or freedom from late rejection, the authors concluded that routine surveillance biospies beyond 6 months are not necessary.
51. Balzer DT, Moorhead S, Saffitz JE, Huddleston CB, Spray TL, Canter CE: Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant 1995, 14:1095-1101. A study in pediatric heart transplant recipients that showed surveillance biopsies beyond 6 months after transplantation rarely yielded positive results.
52. Fisher PE, Suciu-Foca N, Ho E, Michler RE, Rose EA, Mancini D: Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. J Heart Lung Transplant 1995, 14:1156-1161.
53. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH: Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995, 346:1318-1322. Study relating HLA-DR mismatching to number of rejection episodes and graft survival.
54. Pellicelli AM, Cosial JB, Ferranti E, Gomez A, Borgia MC: Alteration of left ventricular filling evaluated by Doppler echocardiography as a potential marker of acute rejection in orthotopic heart transplant. Angiology 1996, 47:35-41.
55. Benvenuti C, Bones PN, Loisance D: Increased serum nitrate concentration in cardiac transplant patients: a marker for acute allograft cellular rejection. Transplantation 1996, 61:745-749.
56. Anderson JR, Hossein-Nia M, Brown PA, Corbishley C, Murday AJ, Holt DW: Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection. J Heart Lung Transplant 1995, 14:666-670.
57. Hossem-Nia M, Holt DW, Anderson JR, Murday AJ: Cardiac troponin I release in heart transplantation [letter]. Ann Thorac Surg 1996, 61:277-278.
58. Ansari AA, Mayne A, Sundstrom JB, Gravanis MB, Kanter K, Sell KW, Villinger F, Siu CO, Herskowitz A: Frequency of hypoxanthine guanine phosphoribosyltransferase (HPRT) T cells in the peripheral blood of cardiac transplant recipients: a noninvasive technique for the diagnosis of allograft rejection. Circulation 1995, 92:862-874.
59. Lagoo AS, George JF, Naftel DC, Griffin AK, Kirklin JK, Lagoo-Deenadayalan S, Hardy KJ, Savunen T, McGiffin DC: Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. J Heart Lung Transplant 1996, 15:206-217.